PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Harvard Medical School, Boston, MA, USA.\', \'Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Boston Children\'s Hospital, Boston, MA, USA.\', \'University of Washington, Seattle, WA, USA.\', \'Fractal Therapeutics, Cambridge, MA, USA.\', \'Boston University, Boston, MA, USA.\', \'Fractal Therapeutics, Cambridge, MA, USA. arijit@fractaltx.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-02148-8
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34799659
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all